Roivant Sciences Ltd. Income Statement

Income Statement Mar2021 Dec2021 Mar2022 Dec2022 Mar2023 Dec2023 Mar2024 Dec2024 Mar2025
Revenue & cost
Revenue 23.80M727.93M55.29M873.43M31.53M991.11M32.71M1128.01M29.05M
Gross Profit 21.74M727.93M46.32M873.43M28.50M991.11M31.11M1128.01M28.14M
Operating items
Research & Development 236.63M483.04M454.06M439.91M550.41M
Selling, General & Administrative 259.88M775.03M383.45M416.13M591.41M
Other Operating Expenses 598.19M66.47M100.78M28.05M0.91M
Operating Expenses 1094.69M1406.93M938.29M884.09M1142.73M
Operating Income -1070.90M-1351.64M-906.76M4497.03M-1003.29M
EBIT -1070.90M-1351.64M-906.76M4497.03M-1003.29M
Non-operating items
Non Operating Investment Income 95.53M443.75M-20.82M-47.97M55.19M
Interest & Investment Income 0.37M32.18M146.43M258.38M
Other Non Operating Income -8.70M3.24M-0.49M-13.56M-10.72M
Non Operating Income -8.70M-179.00M-163.09M1196.88M-112.41M
Net income details
EBT -898.55M-923.75M-884.99M4567.86M-681.59M
Tax Provisions 1.69M0.37M4.08M21.50M48.17M
Profit After Tax -900.23M-92.49M-924.12M-190.24M-1115.46M-395.19M4662.70M-105.03M-729.80M
Income from Non-Controlling Interests -91.00M-78.85M-106.43M-117.72M-184.75M
Income from Continuing Operations -900.23M-924.12M-889.07M4546.35M-729.76M
Consolidated Net Income -900.23M-924.12M-226.39M-315.15M373.19M
Income towards Parent Company -900.23M-924.12M-226.39M-315.15M373.19M
Net Income towards Common Stockholders -900.23M-924.12M-226.39M-315.15M373.19M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M-0.00M
Shares Outstanding (Weighted Average) 51.34M684.79M692.07M725.42M758.43M803.92M805.85M727.95M713.55M
Shares Outstanding (Diluted Average) 686.59M669.75M713.32M712.79M844.46M831.05M731.32M725.40M
EBITDA -1070.90M-1351.64M-906.76M4497.03M-1003.29M
Shares Outstanding 651.58M692.01M694.98M726.80M760.14M804.89M806.68M719.63M695.94M
Tax Rate 0.00M